scholarly journals RELAY, Ramucirumab Plus Erlotinib Versus Placebo Plus Erlotinib in Patients with Untreated, Epidermal Growth Factor Receptor Mutation-Positive, Metastatic Non-Small-Cell Lung Cancer: Safety Profile and Manageability

Drug Safety ◽  
2021 ◽  
Author(s):  
Ernest Nadal ◽  
Hidehito Horinouchi ◽  
Jin-Yuan Shih ◽  
Kazuhiko Nakagawa ◽  
Martin Reck ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Epidermal Growth Factor Receptor ◽  
Growth Factor ◽  
Epidermal Growth Factor ◽  
Small Cell Lung Cancer ◽  
Safety Profile ◽  
Growth Factor Receptor ◽  
Small Cell ◽  
Small Cell Lung ◽  
Epidermal Growth

Comparison of the Efficacy of Gefitinib in Patients with Non-Small Cell Lung Cancer according to the Type of Epidermal Growth Factor Receptor Mutation

Oncology ◽  
2014 ◽  
Vol 87 (4) ◽  
pp. 215-223 ◽  
Author(s):  
Satoshi Igawa ◽  
Masashi Kasajima ◽  
Mikiko Ishihara ◽  
Michiko Kimura ◽  
Yasuhiro Hiyoshi ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Epidermal Growth Factor Receptor ◽  
Growth Factor ◽  
Epidermal Growth Factor ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Growth Factor Receptor ◽  
Small Cell ◽  
Small Cell Lung ◽  
Epidermal Growth
Sign in / Sign up

Export Citation Format

Share Document